Last reviewed · How we verify
NCT04171609
Expressive Writing for Cancer Survivors
NA trial testing Expressive writing in Cancer Survivors in 14 participants. Completed in 14 May 2020.
14 May 2020
Quick facts
| Lead sponsor | Duke University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 14 |
| Start date | 19 July 2019 |
| Primary completion | 14 May 2020 |
| Estimated completion | 14 May 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Expressive writing
Conditions studied
- Cancer Survivors — all drugs for Cancer Survivors →
Sponsor
Duke University
Who can join
18 and older, any sex, with Cancer Survivors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04171609
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Expressive writing
Trials testing the same drug.
- NCT06893627 — Body Project SMIL: Prevention of Eating Disorders Among Young Women With Psychiatric Illness With the Body Project · NA · not yet recruiting
- NCT06238141 — Expressive Writing on Stress-Related and Work-Related Outcomes Among Chinese Nursing Interns · NA · completed
- NCT06872268 — APPLICATION OF THERAPEUTIC PHOTOGRAPHY AND EXPRESSIVE WRITING IN THE MANAGEMENT OF PATIENTS WITH MARFAN SYNDROME · NA · completed
- NCT06230068 — ExBRAC - the Pilot Study · NA · completed
- NCT05863598 — Prevention of Eating Disorders Through Optimization of Protective Factors · NA · recruiting
Other recruiting trials for Cancer Survivors
Currently open trials in the same condition.
- NCT06778122 — In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors · NA · recruiting
- NCT05179408 — Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer · NA · recruiting
- NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
- NCT06769165 — EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors · NA · recruiting
- NCT06904495 — Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age · NA · recruiting
Other Duke University trials
Trials by the same sponsor.
- NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
- NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
- NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
- NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
- NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04171609 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Duke University
- Last refreshed: 25 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04171609.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing